Drug intelligence / Profile preview

Tauroselcholic acid

Development stage
Unknown
Lead developer
General Electric
Modality
Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Oral
01

Overview

Tauroselcholic acid (SeHCAT) is a synthetic, radiolabeled analog of the naturally occurring bile acid conjugate taurocholic acid. It incorporates the gamma-emitting isotope selenium-75 and is used as a diagnostic agent to assess bile acid malabsorption, particularly in patients with chronic diarrhea or suspected ileal dysfunction. After oral administration, it mimics the physiological behavior of natural bile acids—being absorbed in the terminal ileum and undergoing enterohepatic circulation. Its retention or excretion can be measured using gamma cameras to evaluate intestinal absorption and function. The test has largely replaced older methods for assessing bile salt turnover due to its accuracy and convenience[1][4][5][7][8].

Brand names
SeHCAT
Other names
Tauroselcholic acid75Se-tauroselcholic acid
02

Targets

SLC10A2 (Solute carrier family 10 member 2)

Beyond the preview

Go deeper on Tauroselcholic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tauroselcholic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call